维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

18篇 您的检索式：作者名="Roboz G J"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Phase 1 study of PTK787/ZK 222584, a small molecule tyrosine kinase receptor inhibitor, for the treatment of acute myeloid leukemia and myelodysplastic syndrome显示文摘	ROBOZ G J GILES FJ LIST A F	2006	Leukemia2006，20，6：	1
	2	Arsenic trioxide induces does-and-time-dePendent aPoPtosis of endothelium and may exert an antileukemic effect via inhibition of angiogenesis显示文摘	Roboz G J DiAs S Lam G	2000	Blood2000，96，：	1
	3	Arsenic trioxide induces dose-and time-dependent apoptosis of endothelium and may ex err an antileukemic effectviainhibition of angiogenesis 显示文摘	Roboz G J Dias S Lam G	2000	Blood2000，96，4：	1
	4	Phase 1 study of epigenetic prim ingwith decitabine prior to standard induction chem otherapy forpatients with AM L显示文摘	Scandura JM Roboz G J		Blood0，2011，118：	1
	5	Arsenictrioxide induces dose and time dependent apoptosis of endothelium and may exerts antileukemic effect via inhibition of angiogenesis显示文摘	Roboz G J Dias S Lam G	2000	Blood2000，96，4：	1
	6	Arsenic trioxide induces dose-and time-dependent apoptosis of endothelium and may exert on antileukemia effect via inhibition of angiogenesis 显示文摘	ROBOZ G J DIAS S LAM G	2000	Blood2000，96，：	1
	7	Arsenic rioxide induce dose and time-dependent apoptosis of endothelium and may exert an anti-leukemic effect via inhibition of angiogenesis显示文摘	Roboz G J Dias S Lam G	2000	Cancer2000，85，2：	1
	8	Phase 1 study of epigenetic priming with decitabine prior to standard induction chemotherapy for patients with AML 显示文摘	SCANDURA J M ROBOZ G J MOH M	2011	Blood2011，118，6：	1
	9	An open-label study of CEP-701 in patients with JAK2 V617F-positive polycythemia vera and essential thrombocytosis 显示文摘	MOLITERNO A R ROBOZ G J CARROLL M	2008	Blood2008，112，：	1
	10	Phase 1 study of epigenetic priming with decitabine prior to standard induction chemotherapy for patients with AML显示文摘	Scandura JM Roboz G J Moh M	2011	Blood2011，118，：	1
	11	A pharmaeodynamie study of the FLT3 inhibitor KW-2449 yields insight into the basis for clin- ical response 显示文摘	Pratz KW Cortes J Roboz G J	2009	Blood2009，113，17：	1
	12	Arsenic trioxide and low-dose cytarabine in older patients with untreated acute mye loid leukemia, excluding acute promyelocytic leukemia 显示文摘	Roboz G J Ritchie E K Curcio T	2008	Cancer2008，113，9：	1
	13	Novel approaches to the treatment of acute myeloid leukemia显示文摘	ROBOZ G J	2011	Hematology2011，，：	1
	14	Pregnancy in a woman with chronic neutrophilic leukemia 显示文摘	Taylor J Roboz G J Baergen R N	2013	Obstet Gyne- col2013，121，221：	1
	15	Arsenic trioxide and low-dose, cytarabine for patients with intermediate-2 and high-risk myelodysplastic syn- drome显示文摘	Roboz G J Ritchie EK Curcio T	2010	Leuk Res2010，35，4：	1
	16	Current treatment of acute myeloid leukemia 显示文摘	Roboz G J	2012	Curr Opin Oncol2012，24，6：	1
	17	Arsenic trioxide induces doseand time-dependent apoptosis of endothelium and may exert an antileukemie effect via inhibition of angiogenesis显示文摘	Roboz G J Dias S Lam G	2000	Blood2000，96，4：	1
	18	Troxacitabine administered by continuous infusion (CI) is well tolerated and effective in adults with relapsed or refractory acute myeloid leukemia (AML)显示文摘	Roboz G Jolivet J Kelner M	2005	Proc Am Soc Clin Oncol2005，23，：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费